| An RNAi therapeutic targeting hepatic DGAT2 in a genetically obese mouse model of nonalcoholic steatohepatitis B Yenilmez, N Wetoska, M Kelly, D Echeverria, K Min, L Lifshitz, ... Molecular Therapy 30 (3), 1329-1342, 2022 | 23 | 2022 |
| Paradoxical activation of transcription factor SREBP1c and de novo lipogenesis by hepatocyte-selective ATP-citrate lyase depletion in obese mice B Yenilmez, M Kelly, GF Zhang, N Wetoska, OR Ilkayeva, K Min, ... Journal of Biological Chemistry 298 (10), 2022 | 5 | 2022 |
| Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitis K Min, B Yenilmez, M Kelly, D Echeverria, M Elleby, LM Lifshitz, ... Elife 12, RP89136, 2024 | 3 | 2024 |
| Crosstalk between corepressor NRIP1 and cAMP signaling on adipocyte thermogenic programming E Tsagkaraki, A Guilherme, SM Nicoloro, M Kelly, LM Lifshitz, H Wang, ... Molecular Metabolism 76, 101780, 2023 | 1 | 2023 |
| Investigating the correlation between early vascular alterations and cognitive impairment in Alzheimer’s disease in mice with SD-OCT JH Lee, S Stefan, K Walek, J Nie, K Min, TD Yang, J Lee Biomedical Optics Express 14 (4), 1494-1508, 2023 | 1 | 2023 |
| Dual targeting of hepatocyte DGAT2 and stellate cell FASN alleviates nonalcoholic steatohepatitis in mice B Yenilmez, S Harney, C DiMarzio, M Kelly, K Min, D Echeverria, ... bioRxiv, 2023 | | 2023 |
| The Therapeutic Potential of Targeting Hepatic MCT1 in Non-Alcoholic Steatohepatitis K Min UMass Chan Medical School, 2023 | | 2023 |
| Paradoxical activation of SREBP1c and de novo lipogenesis by hepatocyte-selective ACLY depletion in obese mice B Yenilmez, M Kelly, G Zhang, N Wetoska, OR Ilkayeva, K Min, L Rowland, ... bioRxiv, 2022.03. 21.485183, 2022 | | 2022 |
